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osting by EAbstract Posterior eyelid ptosis repair via the Mu¨ller’s muscle-conjunctival resection procedure is
an effective, reliable, and simple technique for periorbital rejuvenation in the aesthetic patient. This
procedure may be performed with other periorbital rejuvenation techniques without sacriﬁcing
results. Appropriate candidates are patients with maintained levator function whose ptotic upper
eyelid elevates close to a normal eyelid level upon instillation of phenylephrine drops to the superior
conjunctival fornix.
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Posterior eyelid ptosis repair via the Mu¨ller’s muscle-conjunc-
tival resection procedure with or without blepharoplasty is a
valuable technique for periorbital rejuvenation in the aesthetic
patient. The surgeon’s ability to recognize eyelid ptosis and to
ease in performing posterior eyelid surgical procedures is par-
amount in successfully integrating this technique into your sur-
gical armamentarium.
Age-related or involutional ptosis is common and must not
be overlooked in preoperative evaluation of an aesthetic pa-
tient. In our practice, patients often do not recognize the dif-
ference between upper eyelid ptosis and dermatochalasis. A
detailed examination, including eyelid measurements and pro-
vocative testing, is important in determining the aesthetic and
functional potential of eyelid ptosis repair with or without
blepharoplasty.
Posterior eyelid surgical approaches may be daunting to the
surgeon unfamiliar with surgical anatomy of the eyelid and or-
bit. In addition, the close proximity to the globe and the poten-
tial for vision-threatening complications are variables that only
clinical experience will alleviate. Appropriate selection of sur-
gical candidates with realistic goals is vital in developing the
skills necessary to feel at ease with posterior eyelid surgical
approaches.
The following sections will detail the preoperative evalua-
tion/planning, surgical technique, postoperative management,
and potential complications of posterior eyelid ptosis repair
via the Mu¨ller’s muscle-conjunctival resection procedure with
or without blepharoplasty.
2. Preoperative evaluation
2.1. Degree of eyelid ptosis – see Fig. 1A
The margin–reﬂex distance 1 (MRD1) measurement is used to
assess the upper eyelid position. The examiner holds a point
light source at eye level directly in front of the patient andthe patient is asked to gaze at the light. The distance from
the corneal light reﬂex to the central upper eyelid margin is
the MRD1. The MRD1 is measured in positive millimeters if
the eyelid is above the corneal light reﬂex and measured in neg-
ative millimeters if the eyelid obscures the corneal light reﬂex.
In unilateral cases of upper eyelid ptosis, the difference in
MRD1 of the normal side and the ptotic side indicates the
amount of ptosis. The normal MRD1 is approximately 3.5–
4.5 mm; this value may be used to determine the amount of
ptosis in bilateral cases. The MRD1 is a more valuable clinical
measurement compared to the vertical palpebral ﬁssure as it is
independent of the lower eyelid position.2.2. Levator muscle function – see Fig. 1B and C
Levator function (LF) is used to assess the overall effectivity of
the levator muscle/aponeurosis as an eyelid retractor. The leva-
tor muscle/aponeurosis is the principal eyelid retractor and de-
creased function may suggest dysgenesis of the levator muscle,
abnormal innervation to the levator muscle, or traumatic dis-
insertion of the levator muscle/aponeurosis. The LF is mea-
sured as the excursion, in millimeters, of the upper eyelid
from downgaze to upgaze with the frontalis muscle immobi-
lized. The normal LF is approximately 15 mm. The frontalis
muscle is an accessory eyelid retractor and if not immobilized
will erroneously result in a higher LF measurement.2.3. Phenylephrine test – see Fig. 2A and B
The Mu¨ller’s muscle is a smooth muscle that is sympathetically
innervated and involuntarily elevates the upper eyelid 2–3 mm
(Beard, 1985). Its origin extends from the posterior aspect of
the levator muscle and inserts at the superior tarsal margin
(Mu¨ller et al., 1859; Dutton, 1994). The phenylephrine test
uses an adrenergic agonist to stimulate the Mu¨ller’s muscle
and to elevate the upper eyelid. The phenylephrine test is
performed in three steps (Putterman and Urist, 1975). First,
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Second, topical tetracaine drops are applied to the ocular sur-
face and the patient’s head is tilted backwards, the upper eyelid
is elevated, and the patient is asked to gaze downwards. Sev-
eral drops of 2.5–10% phenylephrine are instilled into the
superior conjunctival fornix; this is repeated 2–3 additional
times (Glatt et al., 1990). The patient is positioned in this man-
ner to maximize effect on Mu¨ller’s muscle and minimize ocular
and systemic absorption. Finally, the MRD1 is re-measured 3–
5 min after instillation of the phenylephrine. The amount of
upper eyelid elevation is used to determine the amount of Mu¨l-
ler’s muscle-conjunctival resection.
Prior to performing the phenylephrine test, the patient’s
clinical history should be thoroughly reviewed. Patients with
a history of unstable or severe cardiac disease, hypertension,
or angle-closure glaucoma should be excluded as systemic
absorption of the phenylephrine may precipitate heart block,
myocardial infarction, hypertensive crisis, or acute angle clo-
sure glaucoma (Glatt et al., 1990).3. Anesthesia
The Mu¨ller’s muscle-conjunctival resection ptosis procedure
may be performed with minimal patient discomfort under local
anesthesia consisting of 2% lidocaine with 1:100,000 U of epi-
nephrine. In patients undergoing several concurrent periorbital
rejuvenation procedures, oral/intravenous sedation or general
anesthesia may be used without modifying the technique or
decreasing the effectiveness or reliability of the postoperative
result. This is not the case when performing an external levator
advancement/resection ptosis repair procedures as patients
should be conscious to optimize intraoperative adjustments
(Ben Simon et al., 2005).4. Surgical technique
Once the preoperative evaluation is complete, it is vital to
recruit the appropriate patients for posterior approach ptosis
repair using the Mu¨ller’s muscle-conjunctival resection proce-
dure. Historically, patients with mild (62 mm) ptosis were con-
sidered appropriate, however, a recent study indicates that
patients with moderate and moderate to severe ptosis may also
be candidates. This suggests that patients with intact levator
function (P10 mm) and a response to the phenylephrine test
are suitable for the Mu¨ller’s muscle-conjunctival resection
procedure.
In the initial report of the surgical technique (Putterman
and Urist, 1975), a response to the phenylephrine test in which
the ptotic eyelid elevated to a normal level, 8.25 mm of
Mu¨ller’s muscle and conjunctiva is excised. A 6.25- 9.75-mm
graded resection of Mu¨ller’s muscle and conjunctiva is
performed if the ptotic eyelid elevates slightly higher or lower
than the normal eyelid or ideal eyelid position, respectively
(Putterman and Fett, 1986). Several studies have attempted
to develop an algorithm to determine the appropriate amount
of Mu¨ller’s muscle-conjunctival resection, however, results
have been variable and no method has been universally ac-
cepted (Mercandetti et al., 2001; Ben Simon et al., 2007; Ayala
et al., 2007; Dresner, 1991; Perry et al., 2002). Clinical experi-
ence correlated with an individual surgeon’s postoperativeresults is the most predictive factor in obtaining serial reliable
operative results.
4.1. Step 1 – see Fig. 3A and B
A sterile marking pen is used to mark the upper eyelid skin
prior to injection of local anesthetic. The eyelid crease incision
may be marked along the patient’s natural eyelid crease, how-
ever, in patients with upper eyelid ptosis the eyelid crease may
be displaced superiorly or poorly deﬁned. This is often the case
in patients with aponeurotic or involutional eyelid ptosis, the
most common cause of eyelid ptosis in adults. Therefore, the
crease may be measured and marked according to the pa-
tient/surgeon preference in regard to gender, ethnicity, antici-
pated prominence of the upper eyelid skin fold, and brow
position.
The height of the eyelid crease above the eyelid margin may
be marked at three positions (the upper punctum, the mid-pu-
pil, and the lateral canthal angle) and connected in a curvilin-
ear manner extending 1–1.5 cm temporally in a slightly upward
direction. In men, the marks are usually 8 mm nasally, 10 mm
centrally, and 9 mm temporally. In women, the marks are usu-
ally 9 mm nasally, 11 mm centrally, and 10 mm temporally
(Putterman and Fagien, 2008).
A skin ‘‘pinch’’ technique may be employed to determine
the amount of upper eyelid skin to be excised. A smooth for-
ceps is used to grasp the eyelid skin at the mid-pupil crease
mark and several millimeters above, in order to ‘‘pinch’’ the
redundant eyelid skin and slightly evert the eyelashes without
elevating the eyelid, and marked. This is repeated at the upper
punctum and lateral canthal angle marks. The markings are
connected in a curvilinear fashion and joined at the nasal
and temporal ends to the eyelid crease marking.
4.2. Step 2 – see Fig. 3C
A small amount (0.5–1.0 mL) of local anesthetic is injected be-
low the skin adjacent to the superﬁcial skin markings. Overag-
gressive instillation of local anesthetic may cause inadvertent
contraction of Mu¨ller’s muscle in response to the epinephrine,
as well as, making eyelid eversion more difﬁcult. A surgical
blade is used to make a superﬁcial skin incision along the sur-
gical markings.
4.3. Step 3 – see Fig. 4
A 23-gauge retrobulbar needle is used to perform a frontal
nerve block (Hildreth and Silver, 1976). This allows for sufﬁ-
cient anesthesia during the procedure without compromising
normal eyelid architecture. One should palpate the supraor-
bital notch along the nasal aspect of the superior orbital rim
to prevent inadvertent injury to the supraorbital neurovascular
bundle. The retrobulbar needle is inserted into the superior or-
bit approximately 5–10 mm temporal to the supraorbital
notch. The needle should hug the roof of the orbit during
insertion and advanced to a depth of 4.0 cm; 1.5 mL of local
anesthetic is injected. The needle should be withdrawn along
the same path of insertion to avoid injury to the globe and
orbital structures. Additional local anesthetic (0.25 mL) is in-
jected subcutaneously over the center of the eyelid above the
eyelid margin (see Fig. 5A).
Figure 1 (A) Margin–reﬂex distance 1 (MRD1): The distance from the corneal light reﬂex to the central upper eyelid margin. The MRD1
is +4 mm and +2 mm for the right and left upper eyelid, respectively. (B) Measuring the amount of levator function: marking the upper
eyelid position in downgaze. (C) Marking the upper eyelid position in upgaze with the frontalis muscle immobilized; the excursion of the
eyelid in downgaze to upgaze represents the levator function.
Figure 2 A 37-year-old African-American woman presenting with left upper eyelid ptosis. (A) Prior to instillation of 2.5%
phenylephrine drops. (B) Five minutes after instilling several drops of 2.5% phenylephrine onto the left superior fornix.
Figure 3 (A) The upper eyelid crease is marked and the skin ‘‘pinch’’ technique is used to determine the amount of upper eyelid skin to
be excised. (B) The upper eyelid markings designate an ellipse of tissue to be excised. Note that the markings are positioned superior to the
lateral canthus, mid-pupil, and upper punctum. (C) After a small amount of local anesthetic is injected below the skin, a surgical blade is
used to make a superﬁcial skin incision along the skin markings.
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Figure 4 Frontal nerve block: A sagittal view of the orbit
detailing the path of the retrobulbar needle along the roof of the
orbit.
Figure 5 Silk traction suture. (A) A small amount of local
anesthetic is injected under the skin above the eyelashes at the
central upper eyelid. (B) A 4-0 silk suture is passed through skin,
orbicularis, and superﬁcial tarsus approximately 2 mm above the
eyelid margin.
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A 4-0 silk traction suture is passed through skin, orbicularis
muscle, and superﬁcial tarsus 2 mm above the eyelid margin
at the center of the eyelid (see Fig. 5B). The silk traction suture
is pulled superiorly and the eyelid is everted over a Desmarres
retractor to expose the palpebral conjunctiva from the superiortarsal border to the conjunctival fornix. The size of the Des-
marres retractor will depend on the laxity of the upper eyelid
and the amount of conjunctiva–Mu¨ller’s muscle to be excised;
a medium and large-sized Desmarres retractor should be avail-
able. Several drops of topical tetracaine solution are irrigated
over the globe and palpebral conjunctiva.
4.5. Step 5 – see Fig. 6A
A caliper is set at the amount of conjunctiva–Mu¨ller’s muscle
to be excised. One arm of the caliper is placed at the superior
tarsal border and the other arm facilitates accurate placement
of a 6-0 silk marking suture. The marking suture is passed
through conjunctiva centrally and approximately 7 mm nasally
and temporally. It is important to engage only conjunctiva
during placement of the marking suture as inadvertent passage
through Mu¨ller’s muscle may result in subconjunctival
hemorrhage.
4.6. Step 6 – see Fig. 6B
A toothed forceps is used to ﬁrmly grasp the conjunctiva and
Mu¨ller’s muscle between the superior tarsal border and the silk
marking suture in order to separate Mu¨ller’s muscle from the
underlying levator aponeurosis. This maneuver is possible be-
cause Mu¨ller’s muscle is ﬁrmly attached to conjunctiva and
only loosely adherent to the levator aponeurosis. Mild inferior
rotation of the Desmarres retractor will decrease tension on
the eyelid allowing for greater separation of the structures dur-
ing this maneuver.
4.7. Step 7 – see Fig. 7A and B
One blade of a specially designed clamp (Putterman Mu¨ller
muscle–conjunctival resection clamp, Bausch & Lomb, Man-
chester, MO) is placed at the level of the silk marking su-
ture. Each tooth of this blade engages the silk marking
suture at its passage through the conjunctiva. The Desmar-
res retractor is slowly rotated from under the eyelid as the
outer blade of the clamp engages the conjunctiva and Mu¨l-
ler’s muscle at the superior tarsal border. Any entrapped
tarsus is pulled free from the clamp with the surgeon’s
thumb (see Fig. 8A). The clamp is ﬁrmly compressed and
the handle locked in position incorporating the palpebral
conjunctiva and Mu¨ller’s muscle between the superior tarsal
border and the silk marking suture. It is important that the
placement of the clamp should reﬂect the relative position of
the tarsal plate. In elderly patients or patients with signiﬁ-
cant upper eyelid laxity, the tarsus is attenuated and, often,
temporally displaced; the clamp should be adjusted tempo-
rally to avoid eyelid contour abnormalities.
4.8. Step 8 – see Fig. 8B
The upper eyelid skin is pulled superiorly while the clamp is
pulled in the opposite direction. If signiﬁcant tension or a sense
of attachment is noted between the skin and clamp during this
maneuver, then the levator aponeurosis is likely incarcerated
within the clamp; the clamp should be released and reapplied
as instructed in Step 7. This maneuver is possible because
Figure 6 (A) Silk marking suture: The upper eyelid is everted over a Desmarres retractor and a caliper is used to measure the distance
above the superior tarsal margin. A 6-0 silk suture is passed through conjunctiva centrally and 7 mm nasally and temporally. (B) A
toothed forceps is used to ﬁrmly grasp the conjunctiva and Mu¨ller’s muscle between the superior tarsal border and the silk marking suture
in order to separate Mu¨ller’s muscle from the underlying levator aponeurosis.
Figure 7 Application of the Putterman Mu¨ller’s muscle–conjunctival resection clamp. (A) One blade the clamp is placed at the level of
the silk marking suture. Each tooth of this blade engages the silk marking suture at its passage through the conjunctiva. (B) The
Desmarres retractor is slowly rotated from under the eyelid as the outer blade of the clamp engages the conjunctiva and Mu¨ller’s muscle at
the superior tarsal border.
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muscle and skin to form the eyelid crease.
4.9. Step 9 – see Fig. 9A and B
With the clamp held vertically, a double-armed 5-0 plain gut su-
ture is run in a horizontal mattress fashion approximately1.5 mm below the margin of the clamp along its entire width
in a temporal to nasal fashion. The suture is passed through
the conjunctiva and superior tarsal margin on one side of the
clamp and conjunctiva and Mu¨ller’s muscle on the opposite
side of the clamp. In effect, the conjunctiva–Mu¨ller’s muscle
complex is advanced and reattached to the superior tarsal bor-
der. The suture passes are positioned adjacent to one another
Figure 8 (A) Any entrapped tarsus is pulled free from the clamp with the surgeon’s thumb. B: The upper eyelid skin is pulled superiorly
while the clamp is pulled in the opposite direction. If signiﬁcant tension or a sense of attachment is noted between the skin and clamp
during this maneuver, then the levator aponeurosis is likely incarcerated within the clamp.
Figure 10 Resection of Mu¨ller’s muscle and conjunctiva: A #15
surgical blade is used to excise the tissue within the clamp by
cutting between the suture and the clamp.
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clamp. This method decreases the corneal irritation and foreign
body sensation experienced by the patient postoperatively.
4.10. Step 10 – see Fig. 10
A #15 surgical blade is used to excise the tissue within the
clamp by cutting between the suture and the clamp. The
blade is beveled upward in direct contact with the clamp
to prevent inadvertent lysis of the running suture. In addi-
tion, the surgeon must be careful not to cut the arms of
the suture on either the nasal or the temporal end of the
clamp.
4.11. Step 11 – see Fig. 11A
The Desmarres retractor is positioned to evert the eyelid while
gentle traction is applied to the silk traction suture. The nasal
arm of the plain gut suture is run in a continuous fashion in a
temporal direction incorporating the superior tarsal border,
Mu¨ller’s muscle, and conjunctiva; each suture pass should be
2–3 mm apart. Great care must be taken to avoid cutting the
original mattress suture with each pass; gentle suction and ade-
quate hemostasis at the wound edges should be maintained. In
addition, selection of a plain gut suture with a small, spatu-
lated needle will help prevent inadvertent suture lysis.Figure 9 Advancement of Mu¨ller’s muscle and conjunctiva. (A) A d
fashion approximately 1.5 mm below the margin of the clamp along its
margin of resection adjacent to the superior conjunctival fornix. (B) V4.12. Step 12 – see Fig. 11B
Once the nasal arm of the plain gut suture reaches the tempo-
ral aspect of the wound, each arm of the suture is passedouble-armed 5-0 plain gut suture is run in a horizontal mattress
entire width in a temporal to nasal fashion. View along the superior
iew along the superior tarsal border.
Figure 11 Closure of conjunctival wound. (A) The nasal arm of the plain gut suture is run in a continuous fashion in a temporal
direction incorporating the superior tarsal border, Mu¨ller’s muscle, and conjunctiva; each suture pass should be 2–3 mm apart. (B) Once
the nasal arm of the plain gut suture reaches the temporal aspect of the wound, each arm of the suture is passed through conjunctiva and
Mu¨ller’s muscle into the wound.
Figure 12 Completion of upper blepharoplasty. (A) The eyelid skin or skin/orbicularis muscle ﬂap is excised using scissors or an
electrocautery knife. (B) Several 6-0 interrupted sutures reinforce eyelid crease reconstruction. The wound is closed with a 6-0 running
permanent suture.
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arms of the suture are pulled from the interior of the wound
and tied with a surgeon’s knot. The ends of the suture are
cut adjacent to the knot allowing the knot to retract into the
subconjunctival space. This helps to prevent postoperative ker-
atopathy and foreign body sensation. If the patient is undergo-
ing concurrent upper blepharoplasty, the arms of the suture
can be pulled from the interior of the wound and placed aside
without tying the suture. The Desmarres retractor can be re-
moved and the eyelid can be placed in its normal anatomic po-
sition. Once the eyelid skin or skin and orbicularis muscle has
been excised and hemostasis maintained, the knot may be tied
as previously instructed. Performing the excision of skin or
skin/muscle and hemostasis prior to tying the knot will prevent
inadvertent suture lysis.
4.13. Step 13 – see Fig. 12A and B
The eyelid skin or skin/orbicularis muscle ﬂap is excised using
scissors or an electrocautery unit. Careful and aggressive
hemostasis is maintained using unipolar/bipolar cautery. The
eyelid crease is reconstructed by passing 6-0 interrupted su-
tures through the levator aponeurosis and orbicularis at the
three eyelid crease markings. Three 6-0 interrupted sutures
through skin at the inferior wound edge, levator aponeurosis,
and skin at the superior wound edge adjacent to the three eye-lid crease markings reinforce eyelid crease reconstruction. The
wound is closed with a 6-0 running permanent suture.
Orbital fat excision, lacrimal gland repositioning, and gla-
bellar/brow procedures may be performed via the upper bleph-
aroplasty incision.
5. Postoperative management
A topical antibiotic ointment is generously applied over the
surface of the eye at the completion of the procedure. The oint-
ment should be applied 2–3 times daily for the ﬁrst week and
prior to bedtime for an additional week. A systemic antibiotic
is not necessary following this procedure; however, if this pro-
cedure is combined with other periorbital rejuvenation proce-
dures, prophylactic oral antibiotics may be added. Topical
and/or systemic anti-inﬂammatory agents, such as steroids,
are not necessary, but may be given as deemed appropriate.
Cold compresses are applied over the eyelids for the ﬁrst
24 h to help prevent postoperative edema and may be used
thereafter for patient comfort. It is important that patients rec-
ognize that there may be continued sensory anesthesia to the
eyelid 4–6 h after the procedure and cycle the cold compresses
to prevent superﬁcial irritation.
Frequent use of ocular lubricants (drops and ointments) is
important to prevent postoperative keratopathy and patient
discomfort. Patients should be encouraged to use artiﬁcial
Figure 13 A 56-year-old Caucasian woman presenting with bilateral upper eyelid ptosis. (A) Prior to instillation of 10% phenylephrine
drops. (B) Five minutes after instilling several drops of 10% phenylephrine onto bilateral superior fornices. (C) Six weeks following
bilateral Mu¨ller’s muscle–conjunctival resection ptosis procedure combined with bilateral upper and lower blepharoplasty.
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symptoms.
Patients should be instructed to experience worsening eyelid
swelling and ocular discomfort for the ﬁrst 48–72 h following
the procedure. Vision is often blurred and distorted secondary
to uneven tear ﬁlm and frequent ocular lubricant administra-
tion. As the eyelid swelling and ocular discomfort improve,
the patient may be instructed to use the artiﬁcial tears in lieu
of the more viscous ocular lubricants. The eyelid usually at-
tains its ﬁnal level 3–6 weeks postoperatively (see Fig. 13).
6. Complications
The most common complication from posterior eyelid ptosis
repair is corneal irritation and/or abrasion (Putterman and
Fett, 1986). The combination of exposed suture material, post-
operative eyelid edema, and relative increase in exposed ocular
surface area may contribute to corneal epithelial derangement.
Patients with postoperative lagophthalmos are at particular
risk of developing corneal abnormalities and should be
strongly encouraged to maintain an aggressive ocular lubrica-
tion regimen. A bandage contact lens or collagen shield may be
used in symptomatic patients. Rarely, a corneal abrasion may
develop into a corneal ulcer. These patients should be referred
for urgent ophthalmologic evaluation to prevent vision threat-
ening complications.Over- or under-correction of eyelid position is observed in
approximately 3–5% of cases (Putterman and Fagien, 2008).
If a signiﬁcant overcorrection occurs, downward massage of
the eyelid while ﬁxating the brow may be used in the early
postoperative period. If the over-correction persists, a levator
recession procedure can be performed (Putterman and Fagien,
2008). In cases of under-correction, a repeat posterior eyelid
ptosis procedure may be performed, however, results are fre-
quently unpredictable; more often a levator advancement or
resection ptosis procedure is employed.
In rare cases, persistent hemorrhage from the Mu¨ller’s mus-
cle may occur. The Mu¨ller’s muscle is a highly vascularized
structure and patients on anticoagulation therapy, or restart
anticoagulation shortly after the procedure, are at increased
risk. Firm pressure over the eyelid for approximately 5 min
will often cease the hemorrhage, however, persistent hemor-
rhage from the offending wound edge or vessel may require
exploration and cauterization.
7. Conclusion
Posterior eyelid ptosis repair via the Mu¨ller’s muscle-conjunc-
tival resection procedure is an effective, reliable, and simple
technique for periorbital rejuvenation in the aesthetic patient.
Although posterior eyelid approach techniques may be daunt-
ing for the novice eyelid surgeon, with experience and patience,
60 K. Sajja, A.M. Puttermanone will be impressed with the ease and reproducibility of the
procedure as translated to patient satisfaction.Conﬂict of interest
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